Cybin to participate in the alliance global partners healthcare company showcase

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will participate in a fireside chat at the virtual alliance global partners healthcare company showcase, taking place may 21, 2024. mr. drysdale's prese.
CYBN Ratings Summary
CYBN Quant Ranking